Doug Hilton | |
---|---|
![]() Hilton in 2019 | |
Chief Executive of the CSIRO | |
Assumed office 1 July 2023 | |
Preceded by | Larry Marshall |
Personal details | |
Born | Douglas James Hilton 13 June 1964 Eton,Berkshire,England |
Education | East Doncaster High School |
Alma mater | Monash University |
Occupation | Molecular biology and hematopoiesis at the Walter and Eliza Hall Institute of Medical Research |
Douglas James Hilton AO , FAA , FTSE (born 13 June 1964 in England) is an Australian molecular biologist. He is the CEO of CSIRO [1] and immediate past Director of the Walter and Eliza Hall Institute of Medical Research in Melbourne,Australia. His research has focused on cytokines,signal transduction pathways and the regulation of blood cell formation (hematopoiesis). Hilton was the President of the Association of the Australian Medical Research Institutes (AAMRI) from 2014-16. [2]
Hilton migrated to Australia with his family in 1970 and grew up in the Melbourne suburb of Warrandyte. He was educated at Warrandyte Primary School and East Doncaster High School,where he recalls being inspired by “a wonderful biology teacher”. [3]
Hilton received a Bachelor of Science from Monash University. He spent summer holidays as an undergraduate researcher in the laboratory of Ian Young at the John Curtin School of Medical Research. His Honours and PhD research projects were conducted with Professors Don Metcalf and Nicos Nicola at the Walter and Eliza Hall Institute,and resulted in the cloning of the cytokine Leukemia Inhibitory Factor (LIF). [4]
Hilton spent two years as a postdoctoral fellow studying the erythropoietin (EPO) receptor with Professor Harvey Lodish at the Whitehead Institute,MIT,USA. [4] In 1993 Hilton returned to the Walter and Eliza Hall Institute where he continued his research into cytokine signalling,with discoveries including the interleukin-11 receptor,the interleukin-13 receptor,and the Suppressors of Cytokine Signalling (SOCS) proteins. In recent years,together with Professor Warren Alexander and Dr Benjamin Kile,Hilton has established a new program using large-scale mouse genetics and genomics to identify regulators of blood cell formation,with a view to determining targets for the development of new medicines. He has been the head of the Institute's Division of Molecular Medicine since it began in 2006,and is a professor in the University of Melbourne Faculty of Medicine,Dentistry and Health Science.
From 1997 to 2001,Hilton served as Director of the Cooperative Research Centre (CRC) for Cellular Growth Factors, [5] during which he initiated the Australian Undergraduate Research Opportunity Program (UROP). He is also a co-founder and Chief Scientific Officer of the biotechnology company MuriGen Therapeutics. [6] He currently serves on the Board of the Victorian Comprehensive Cancer Centre,the Australian Cancer Research Foundation Medical Research Advisory Committee, [7] the Victorian Cancer Agency Plan Implementation Committee,the Victorian Life Sciences Computational Initiative Steering Committee, [8] the Board of the Bio21 Cluster, [9] and the Board of the National Center for Genetic Engineering and Biotechnology,Thailand. [10]
On 1 July 2009,Hilton became the sixth Director of the Walter and Eliza Hall Institute. [11]
At the time of appointment,Hilton believed that the Institute's success requires:[ citation needed ]
On the 19th of June 2023,it was announced that Doug Hilton was to become the Chief Executive of CSIRO starting 29th of September 2023. [12]
WEHI,previously known as the Walter and Eliza Hall Institute of Medical Research,and as the Walter and Eliza Hall Institute,is Australia's oldest medical research institute. Sir Frank Macfarlane Burnet,who won the Nobel Prize in 1960 for his work in immunology,was director from 1944 to 1965. Burnet developed the ideas of clonal selection and acquired immune tolerance. Later,Professor Donald Metcalf discovered and characterised colony-stimulating factors. As of 2015,the institute hosted more than 750 researchers who work to understand,prevent and treat diseases including blood,breast and ovarian cancers;inflammatory diseases (autoimmunity) such as rheumatoid arthritis,type 1 diabetes and coeliac disease;and infectious diseases such as malaria,HIV and hepatitis B and C.
Sir Gustav Victor Joseph Nossal is an Austrian-born Australian research biologist. He is famous for his contributions to the fields of antibody formation and immunological tolerance.
Donald Metcalf AC FRS FAA was an Australian medical researcher who spent most of his career at the Walter and Eliza Hall Institute of Medical Research in Melbourne. In 1954 he received the Carden Fellowship from the Anti-Cancer Council of Victoria;while he officially retired in 1996,he continued working and held his fellowship until his death in December 2014.
The Eureka Prizes are awarded annually by the Australian Museum,Sydney,to recognise individuals and organizations who have contributed to science and the understanding of science in Australia. They were founded in 1990 following a suggestion by science journalist Robyn Williams.
Suzanne Cory is an Australian molecular biologist. She has worked on the genetics of the immune system and cancer and has lobbied her country to invest in science. She is married to fellow scientist Jerry Adams,also a WEHI scientist,whom she met while studying for her PhD at the University of Cambridge,England.
Ruth Frances Bishop was an Australian virologist,who was a leading member of the team that discovered the human rotavirus.
Michael Cowley FTSE is an Australian physiologist. He is best known for his mapping of the neural circuits involved in metabolism and obesity and diabetes treatment. He is a professor in the Department of Physiology at Monash University in the Faculty of Biomedical and Psychological Sciences. He is also a director of the Australian diabetes drug development company,Verva Inc,and director of the Monash Obesity &Diabetes Institute] (modi).
Brendan Scott CrabbFASM is an Australian microbiologist,research scientist and director and chief executive officer of the Burnet Institute,based in Melbourne,Victoria,Australia.
Andrew Bruce Holmes is an Australian and British senior research chemist and professor at the Bio21 Institute,Melbourne,Australia,and the past President of the Australian Academy of Science. His research interests lie in the synthesis of biologically-active natural products and optoelectronic polymers.
Jane Visvader is a scientist specialising in breast cancer research who works for the Walter and Eliza Hall Institute in Melbourne,Australia. She is the joint head of the Breast Cancer Laboratory with Geoff Lindeman.
Frances Separovic is a biophysical chemist,Distinguished Professor Emeritus of Chemistry,and former Head of the School of Chemistry at the University of Melbourne,where she taught physical chemistry and trained graduate students in her field. She is credited with developing a technique which utilises nuclear magnetic resonance spectroscopy (NMR) to study peptides in aligned lipid bilayers,and has applications in the study of the structure of membrane proteins and their effects on the membrane. Her current research concerns 'the structure and interactions of amyloid peptides from Alzheimer's disease,pore-forming toxins and antibiotic peptides in model biological membranes'.
Linda Richards is an Australian researcher at Queensland Brain Institute (QBI) at the University of Queensland.
Melanie Bahlo is an Australian statistical geneticist and bioinformatician.
Bryan Raymond George Williams Hon. FRSNZ,FAA is a molecular biologist from New Zealand,with expertise in innate immunity and cancer biology. He is emeritus director and distinguished scientist at the Hudson Institute of Medical Research in Melbourne,Australia,and professor in the Department of Molecular and Translational Science at Monash University.
Alan Frederick Cowman AC,FRS,FAA,CorrFRSE,FAAHMS,FASP,FASM is an internationally acclaimed malaria researcher whose work specialises in researching the malaria-causing parasite,Plasmodium falciparum,and the molecular mechanisms it uses to evade host responses and antimalarial drugs. He is currently deputy directory of the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne,and his laboratory continues to work on understanding how Plasmodium falciparum,infects humans and causes disease. He was elected as a fellow of the Royal Society in 2011 and awarded the Companion of the Order of Australia in 2019 for his "eminent service to the biological sciences,notably to molecular parasitology,to medical research and scientific education,and as a mentor."
Professor Anne Kelso is an Australian biomedical researcher specialising in immunology and influenza. She is the Chief Executive Officer of the Australian Government's National Health and Medical Research Council (NHMRC).
Misty Rayna Jenkins is an Australian scientist known for her research into lymphocytes and cancer treatment.
Kathryn "Kat" Elizabeth Holt is an Australian computational biologist specializing in infectious disease genomics. She is a professor at Monash University's Department of Infectious Diseases and a professor of Microbial Systems Genomics at the London School of Hygiene &Tropical Medicine (LSHTM). Her current research focuses on investigating the evolution and dissemination of antimicrobial resistance. In 2015,Holt received the L'Oréal-UNESCO International Rising Talent Award.
Stephen J. Nicholls FRACP,FACC,FESC,FAHA,FAHMS,is an Australian cardiologist. He was appointed to the position of director of MonashHeart,Monash Health and professor of cardiology,Monash University in October 2018. He is the inaugural clinical director of the Victorian Heart Hospital. He is also the inaugural director of Monash University’s Victorian Heart Institute,an organisation dedicated to creating the cardiovascular health solutions of the future.
{{cite web}}
: Missing or empty |title=
(help)